Kevin Michael Esvelt

This inventor holds 23 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Gene Editing Technologies. Top assignees: Harvard College, Massachusetts Institute of Technology, The Invention Science Fund I LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Michael Esvelt. Retrieved from https://idiyas.com/inventor/kevin-michael-esvelt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 14)

% Patents Active = 91.3

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 654(Granted Patents)

Location History:

Cambridge, MA (US) (2014 - 2022)
Auburndale, MA (US) (2017 - 2024)

Company Filing History:

Massachusetts Institute of Technology

patents

2 out of 1,343

The Invention Science Fund I LLC

patents

4. 1 out of 1

The Borad Institute, Inc.

patent

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

CRISPR

Gene Regulation

Gene Drives

RNA-guided

Continuous Evolution

Microbiota Engineering

Frameshift Suppressor

Transcriptional Regulation

Protein Engineering

Cas9 Proteins

Negative Selection

Multiplexing

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577590 - Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing (2026-03-17),

2. 12460201 - Methods of multiplexing CRISPR (2025-11-04),

3. 12433242 - Devices, systems, and methods for introducing organisms into populations (2025-10-07),

4. 12398390 - Negative selection and stringency modulation in continuous evolution systems (2025-08-26),

5. 12366009 - Continuous directed evolution (2025-07-22),

6. 12139708 - Frameshift suppressor tRNA compositions and methods of use (2024-11-12),

7. 11981917 - RNA-guided transcriptional regulation (2024-05-14),

8. 11649469 - Orthogonal Cas9 proteins for RNA-guided gene regulation and editing (2023-05-16),

9. 11214792 - Continuous directed evolution (2022-01-04),

10. 10767194 - RNA-guided transcriptional regulation (2020-09-08),

11. 10752906 - Precise microbiota engineering at the cellular level (2020-08-25),

12. 10640789 - RNA-guided transcriptional regulation (2020-05-05),

13. 10526618 - RNA-guided gene drives (2020-01-07),

14. 10336997 - Continuous directed evolution (2019-07-02),

15. 10329587 - Orthogonal Cas9 proteins for RNA-guided gene regulation and editing (2019-06-25),

Title: The Innovative Mind of Kevin Michael Esvelt

Introduction: Kevin Michael Esvelt is a renowned inventor based in Cambridge, MA (US) known for his groundbreaking work in the field of biotechnology and genetic engineering.

Latest Patents: Kevin Michael Esvelt holds several patents in the areas of gene editing technologies, synthetic biology, and ecological engineering, revolutionizing the way we approach scientific research and environmental conservation.

Career Highlights: With a background in molecular biology and bioinformatics, Esvelt has made significant contributions to the development of CRISPR-based gene drives, aiming to control the spread of infectious diseases and invasive species.

Collaborations: Throughout his career, Kevin Michael Esvelt has collaborated with leading research institutions, universities, and biotechnology companies to further advance the field of genetic engineering and its applications in various industries.

Conclusion: Kevin Michael Esvelt's innovative spirit and dedication to scientific progress continue to inspire new generations of inventors and researchers in the ever-evolving landscape of biotechnology and genetic engineering.

Profile summary based on public USPTO records.